- Research article
- Open Access
Expression, processing and transcriptional regulation of granulysin in short-term activated human lymphocytes
© Latinovic-Golic et al; licensee BioMed Central Ltd. 2007
- Received: 14 August 2006
- Accepted: 27 June 2007
- Published: 27 June 2007
Granulysin, a cytotoxic protein expressed in human natural killer cells and activated T lymphocytes, exhibits cytolytic activity against a variety of intracellular microbes. Expression and transcription have been partially characterised in vitro and four transcripts (NKG5, 519, 520, and 522) were identified. However, only a single protein product of 15 kDa was found, which is subsequently processed to an active 9 kDa protein.
In this study we investigated generation of granulysin in lymphokine activated killer (LAK) cells and antigen (Listeria) specific T-cells. Semiquantitative RT-PCR revealed NKG5 to be the most prominent transcript. It was found to be up-regulated in a time-dependent manner in LAK cells and antigen specific T-cells and their subsets. Two isoforms of 519 mRNA were up-regulated under IL-2 and antigen stimulation. Moreover, two novel transcripts, without any known function, comprising solely parts of the 5 prime region of the primary transcript, were detected. A significant increase of granulysin expressing LAK cells as well as antigen specific T-cells was shown by fluorescence microscopy. On the subset level, increase in CD4+ granulysin expressing cells was found only under antigen stimulation.
Immunoblotting showed the 15 kDa form of granulysin to be present in the first week of stimulation either with IL-2 or with bacterial antigen. Substantial processing to the 9 kDa form was detected during the first week in LAK cells and in the second week in antigen specific T-cells.
This first comprehensive study of granulysin gene regulation in primary cultured human lymphocytes shows that the regulation of granulysin synthesis in response to IL-2 or bacterial antigen stimulation occurs at several levels: RNA expression, extensive alternative splicing and posttranslational processing.
- Lymphokine Activate Killer
- Bacterial Antigen
- Lymphokine Activate Killer Cell
- Short Transcript
A crucial role in destroying tumor cells, virus infected cells and intracellular pathogens is played by natural killer cells (NK) cells and cytotoxic T lymphocytes (CTL) [1–3]. They are armed with cytotoxic granules containing various effector molecules such as granulysin, perforin, and several granzymes [4, 5]. Granulysin, an antimicrobial protein, was first identified by a subtractive hybridization procedure in functional T cell lines and alloantigen and mitogen stimulated PBL and was initially referred to as 519 . A similar gene product, referred to as NKG5, was found in the NK cell line EDF as well as in different T cell lines and clones . Furthermore, Manning et al.  investigated the structure and transcription of the granulysin gene in the functional T cell line AJY and found the alternative spliced transcripts 519, 520, and 522 but no NKG5.
The granulysin gene is located on the human chromosome 2  and comprises 6 exons within a 3.9 kb genomic locus encoding at least four alternatively spliced transcripts (NKG5, 519, 520 and 522), all differing mostly in exon 2. The most abundant transcript in AJY was identified to be 520 appearing late after T cell activation . Since 520 has an appropriate Kozak sequence for the initiation of translation, this transcript was thought to be responsible for the majority of granulysin protein produced . NKG5, which is very similar to 520, but is absent in the AJY, would have the same function in NK cells.
Granulysin is expressed as a 15 kDa protein which is processed by proteolytic cleavage at both N and C termini of the 15 kDa precursor to the active 9 kDa form . Whereas the 15 kDa protein is produced rapidly, has a shorter half-life and is poorly secreted, the secretory 9 kDa form is produced slowly and is relatively stable . Recombinant 9 kDa granulysin exhibits cytolytic activity against microbial and tumor targets [3, 11, 12].
Overall, the complex transcriptional activity of the granulysin gene was found by studying different cell lines but a comprehensive analysis of the granulysin expression in primary cultured lymphocytes has not been performed. It has been shown that granulysin expression is induced in different lymphocyte subsets in response to bacterial antigens [13–15].
In this study, we examined the expression and processing of granulysin in non-transformed lymphocytes which were either stimulated with r-IL-2 (lymphokine activated killer cells LAK cells) or primed by autologous dendritic cells (DC). We used two different bacterial antigens, Listeria innocua and Listeria monocytogenes, which are presented to the immune system in different ways While L. innocua is Gram-positive, non pathogenic, ubiquitous bacterium, which may be processed and presented via the MHC class II pathway, L. monocytogenes is an intracellular pathogen, which can enter the cytosol of infected host cell allowing processing for presentation on MHC class I molecules [16–18]. Both Listeria species have been found to be successfully killed by granulysin [11, 12].
Transcriptional regulation of granulysin in LAK cells
Transcriptional analysis of the granulysin expression has been assessed in cell lines but not in primary cultured lymphocytes. To address this issue we investigated the transcripts encoded by the granulysin gene in freshly isolated PBMC stimulated with IL-2 for 2 weeks.
To investigate whether any transcript includes exons 1 and 2, we performed a RT-PCR using the NKG5 sense B (primer 2) and an antisense primer in exon 2 (primer 6). By this approach two novel short transcripts (ST) were found in LAK cells and in all subsets (Fig. 2A, arrows p38, p25). Sequence analysis revealed ST p25 to comprise exon 1 and exon 2 (see Fig. 1) and ST p38, comprised of p25 plus the whole intron 1, as published by Manning et al. . None of the ST extended to exon 3 (data not shown). Since both ST contain a Kozak consensus translation initiation site, they could be translated into peptides with a length of 25 and 38 amino acids, respectively. The middle band that appears on the agarose gel (Fig. 2A) is the hybridization product of the two ST, with loop formation within intron 1. This was proven by 15 repeated denaturation and annealing steps of the extracted middle band resulting again in 3 bands (data not shown).
Semi-quantitative analysis of the PCR products revealed that in the total population of LAK cells, the NKG5 message increased only slightly by a factor of 1.5 from day 0 to day 15 (p = 0.019), while the two variants of 519 increased by a factor 8.8 (519i; p = 0.002) and 4.4 (519is; p = 0.007), respectively (Fig. 2B).
The ST did not show an apparent IL-2 dependency. Since each donor exhibited a different regulation pattern, a clear tendency for up- or down regulation in response to IL-2 could not be determined (Fig. 2B).
Next, we examined the expression of the various longer transcripts in T cell subsets. Using magnetic beads, CD4+, CD8+ and CD56+ cells were isolated at days 4 and 15 of continuous IL-2 stimulation and RT-PCR analysis was performed. As shown in Figure 2C the highest expressed transcript in all subsets at day 4 is NKG5, while the 519 isoforms are poorly expressed, especially in CD4+ cells. During continuous IL-2 stimulation all transcripts analyzed were at least slightly upregulated in the different cell subsets in all donors tested (Fig. 2C, one representative donor shown).
Short transcripts were also detected in all subsets at days 4 and 15, but their kinetics of expression were not evaluated (data not shown).
Transcriptional regulation of granulysin in antigen specific T-cells
In T cell subsets all transcripts, but especially the 519 isoforms showed prominent upregulation between day 0 and 6. Between day 6 and day 12 no significant difference in the mRNA levels was found (data not shown). Overall these data indicate that especially the two 519 isoforms seem to be tightly regulated on transcriptional level in response to either antigen or IL-2 stimulation
Granulysin expression in LAK cells
These data indicate that in LAK cells the increase in granulysin expression is mostly due to the increasing number and expression level in CD8+ cells as well as the increasing number of CD56+ cells during IL-2 stimulation.
Expression of granulysin in antigen specific T-cells
Analysis of granulysin expression in different subpopulations was done in CD4+ and CD8+ cells separated at day 6 and day 12 and stained for granulysin. In contrast to IL-2 stimulated LAK cells, in L. innocua as well as in L. monocytogenes specific T cells, around 30% CD4+ cells expressed granulysin. Approximately 40% of the CD8+ cells expressed granulysin at day 12 under these conditions (Fig. 6D and 6E). There was a very similar pattern of expression in different subpopulations in the differently primed T cells allowing no conclusion on the preferential presentation in MHC I and MHC II, respectively. As apparent in the graphs there was a higher scattering in the granulysin expression in subsets of cells after antigen specific stimulation compared to LAK cells. This reflects the observation that the T cells of some of the donors were highly responsive to Listeria antigens while others showed only a slight increase in granulysin expression.
High resolution imaging of Listeria- specific T cells after granulysin immunostaining revealed a granular and slightly polarized pattern of granulysin in round shaped cells that are smaller in size compared to LAK cells (Fig. 5B and 5C).
Processing of granulysin in LAK cells and antigen specific T-cells
Activation of T-cells and NK cells can occur through a wide range of stimuli, including bacterial, tumour and viral antigens or cytokines. As a result, these cells express a number of different cytotoxic proteins such as perforin or granzymes to kill target cells or granulysin for killing intracellular bacteria [6, 20–23]. The expression and regulation of granulysin has so far only been studied in cell lines of NK and T-cell origin , where the transcripts NKG5, 520, 522 and 519 have been found. To a limited extent, 519 expression in response to mitogen and alloantigen stimulation was also studied in PBMC . NKG5 was found only in a NK cell line  and was therefore thought to be a NK specific transcript. Transcripts 519, 520 and 522 had been found in AJY, a functional T-cell line . Our newly described variants of 519 as well as the novel short transcripts were not found to be expressed in AJY. On the other side, we could not detect 522 and 520 mRNAs described in AJY. In our system all transcripts detected were expressed both in NK and T-cells. Another striking difference between transcript 519, found in the cell line AJY, and the 519 isoforms in PBMC derived LAK and Listeria specific T-cells, is the absence of exon 1. Currently, it can only be speculated if all these differences are due to a different regulation of granulysin gene expression in primary cultured cells. Of longer transcripts, the constitutively expressed NKG5 mRNA has an appropriate Kozak consensus sequence and a putative hydrophobic leader cleavage site and, as we found, it is also expressed in T-cells. It is most likely the transcript encoding the 15 kDa protein form that is then processed to the active 9 kDa secreted protein in NK and T-cells. In contrast to the NKG5 transcript, the two 519 isoform mRNAs had a very low basal expression and were significantly and strictly upregulated by IL-2 and bacterial antigen, indicating possible contribution of these alternative spliced transcripts in the transcriptional regulation of the granulysin gene. The longer form of the 519 isoform has also one potential in-frame initiation codon but it lacks the Kozak consensus as well as a hydrophobic leader sequence which would suggest that little or no secreted protein is encoded by this transcript. It has indeed been shown that transient expression of 519 cDNA in COS-7 cells did not produce a detectable level of protein . As the 519 short variant does not have an in-frame start codon, its possible impact is rather unclear. The short transcripts (p25 and p38) have the potential to be translated since they could use the same start codon as NKG5 and could enter the secretory pathway, but no experimental evidence is yet available.
As experimental evidence is still missing, we can only speculate how the transcriptional regulation of granulysin gene expression is mediated. The granulysin gene shows extensive alternative splicing which is in contrast to other cytotoxic proteins, such as perforin and granzyme B encoded by only one transcript [6, 24, 25]. For the vast majority of alternative splicing events, the functional significance is unknown. The potential role of alternative splicing and different protein isoforms in the regulation of transcriptional activity has already been reported in humans e.g. for p53 and GLI2 proteins [26, 27]. Willingham et al. found several functional non coding RNAs. Some of them are essential for cell viability, one repressor of Hedgehog signaling and one that acts as repressor of transcription factor NFAT, which is itself required for T-cell receptor-mediated immune response . Some possible functions of non-coding transcripts could be stabilizing of coding transcript or post-transcriptional regulation of gene expression [29, 30]. To find out whether the two novel transcripts (p38 and p25) are translated in CTLs, their possible roles and the function of the 519 isoforms needs further investigations.
It has been reported that primary human NK cells constitutively express granulysin whereas CD8+ cells express granulysin upon stimulation [31–33]. Our results revealed a significant increase in protein levels over time under IL-2 or antigen stimulation observed in the whole cell population Monitoring different subpopulations, IL-2 increased protein synthesis only in CD8+cells. Recently Zheng et al.  showed that IL-2 induces granulysin expression in isolated CD4+ cells. In our system, IL-2 did not induce upregulation of granulysin expression in CD4+ cells, but all transcripts were induced in a time dependent manner. Approximately 10–15% CD4+ cells expressed granulysin between the first and second week of IL-2 stimulation. This discrepancy could be due to the fact that we did not isolate CD4+ out of the whole population prior to stimulation. Similar to our results, Liu et al. showed that IL-2 induced expression of perforin and granzyme A and B was mostly seen in CD8+ subset, but in CD4+ cells they also detected only mRNA [20, 35]. As expected, the CD56+ population showed very high constitutive expression of granulysin protein and messenger. When stimulated with IL-2, CD56+ cells proliferate and after 2 weeks constitute around a half of the whole LAK cell population . Taken together, increased levels of granulysin under IL-2 stimulation, monitored in the whole LAK population is due to an increasing number of CD56+ and CD8+ cells as well as due to the induction of the protein synthesis in CD8+ cells. The number of CD4+ cells decreased under IL-2 stimulation, which could be explained by different expression of IL-2 receptor chains in different T cell subsets [20, 36, 37].
A slightly different pattern was observed in T cells specific for L. innocua or L. monocytogenes, where stimulation with both bacterial antigens revealed a similar phenotype with almost equal proliferation of CD4+ and CD8+ cells. This is in agreement with other studies showing that Listeria antigens may be presented via MHC class I and class II molecules [38–40]. Similar to IL-2 stimulation, the increase in granulysin expression in the whole population was significant over time. In contrast, the percentage of granulysin-expressing cells was rising in both the CD4+ and the CD8+ populations. On mRNA levels after bacterial or cytokine stimulation all transcripts except NKG5 were upregulated between day 0 and 6 after which a plateau was reached (data not shown). This would mean that granulysin availability is delayed after T-cell activation, but supplies are replenished during Ag-specific responses.
Our results confirmed a rather slow kinetic of granulysin production similar to those described for other proteins associated with T cell terminal differentiation such as granzyme and perforin [41, 42]. Studying the kinetics of protein processing proved that IL-2 stimulation leads to processing of granulysin to an active 9 kDa form already in the first week, which is in correlation with data shown by Zheng et al. 2007 where granulysin was detected by day 5, whereas processing under bacterial stimulation occures during the second week of stimulation.
This first comprehensive study reveals various levels of granulysin gene regulation in human primary lymphocytes under different stimuli. It shows a complex transcriptional expression pattern encoding different mRNA variants through use of alternative splicing, followed by cell type specific translational regulation and slow posttranslational processing.
Generation of LAK cells and dendritic cells (DC)
Human DC and LAK cells were generated in vitro from blood-derived precursors as already described . Briefly, human peripheral blood monocytes (PBMC) obtained from venous blood of healthy volunteers were isolated by Ficoll-Paque (Pharmacia Biotech, Uppsala, Sweden) density centrifugation. The PBMC were cultured in RPMI 1640 supplemented with penicillin/streptomycin and 10% human serum (HS) for 2 hours. To obtain dendritic cells (DC), the adherent cells were cultured for 6 days in RPMI 1640 supplemented with penicillin/streptomycin, 5% HS (DC culture medium), recombinant human granulocyte monocyte colony-stimulating factor (rhGM-CSF, 50 ng/ml, Novartis, Basel, Switzerland) and recombinant human IL-4 (100 U/ml, R&D Systems, Abingdon, UK).
The non-adherent cells were cultured in RPMI 1640 supplemented with penicillin/streptomycin (Life Technologies, Paisley, UK), 5% heat-inactivated pooled human A serum (HS, Blood Bank SRK Zürich, Switzerland), and IL-2 (66 U/ml, R&D Systems, Abingdon, UK). On days 0, 4 and 15, phenotypic characterization of the LAK cells was performed by flow cytometry using anti-human CD Abs (see below). On days 4 and 15, different T-cell subpopulations were positively selected by anti-CD4, anti-CD8 and anti-CD56 MicroBeads using Octomacs (Miltenyi Biotec, Bergisch-Gladbach, Germany). Cell purity was more than 90% as assessed by flow cytometry.
Generation of antigen specific T-lymphocytes, autologous mixed leukocyte-DC culture (MLC)
DC were Listeria challenged as described previously [16, 16, 16, 44, 43, 42, 41, 41] Briefly, 6 days matured DC cells were transferred to 6-well plates and challenged with opsonized L. innocua or L. monocytogenes at a multiplicity of infection (MOI) of 10 or Ovalbumin 5 μg/ml for 1 hour at 37°C. Non-internalized bacteria and OVA were removed by washing with PBS before adding media containing 20 μg/ml gentamycin (Sigma, St. Louis, MO). DC washed with equivalent amount of PBS served as a negative control (MOCK). After 16 hours, freshly isolated autologous, nonadherent PBMC in RPMI with 5% HS were added to the challenged DC at the PBMC/DC ratio of 10/1. The MLC was cultured for 6 days before restimulation with fresh Listeria challenged autologous DC. At days 0, 6 and 12 flow cytometry phenotypic analysis of the antigen specific T-cells was performed using anti-human CD Abs (see below). Additionally, at day 6 and day 12, CD4+ and CD8+ cells were separated using MACS beads.
For the phenotyping of the PBMC the following Abs were used according the manufacturers instructions: FITC-labeled anti-human CD4, PE-coupled anti-human CD8, FITC-labeled anti-human CD3, PE-coupled anti-human CD56, (all Diatec.Com AS, Oslo, Norway). Cells were analyzed in FC500 flow cytometer (Beckman Coulter, Fullerton, CA) using CXP software (Beckman Coulter).
Confocal laser scanning microscopy
T-cells or LAK cells were fixed with 1.5% formaldehyde and 1% sucrose in PBS and were cytospun onto glass slides and permeabilized with 0.1% Triton X-100 (Sigma) in PBS for 40 seconds at room temperature. Unspecific binding was blocked with 0.5% BSA (bovine serum albumin, Fluka, Buchs, Switzerland) in PBS for 30 minutes at room temperature. The samples were labeled with guinea pig anti-granulysin antiserum generated in our laboratory as described by Walch et al. . Omitting the first Abs served as control for specificity. For detection FITC-conjugated donkey anti-guinea pig Ab (1/200, Jackson ImmunoResearch, West Grove, PA) was used. For granulysin detection in different LAK subpopulations, the cells were first labeled with anti human CD Abs (see above) for 20 minutes on ice followed by washing in PBS and fixation. Fluorescent labeled specimens were examined using a confocal laser scanning microscope (CLSM SP1, Leica, Heidelberg, Germany).
LAK-cells or antigen specific T-cells (1–3 × 106 cells) were lysed in 0.5% Triton X-100, incubated with 0.4 μg/ml DNAse (Sigma-Aldrich) and subsequently mixed with SDS-PAGE sample buffer followed by separation on 15% SDS-PAGE at 200 V for 45 minutes. The proteins were transferred to an Immobilon-P polyvinylidene fluoride transfer membrane (Millipore, Billerica, MA) at 100 V for 75 minutes. The membrane was blocked using 1% casein (Roche, Basel, Switzerland) in TBS-Tween (0.1%) (Sigma-Aldrich) for 30 minutes. Guinea pig anti-granulysin (1:1000) and goat anti guinea pig HRP (1:5000, Sigma-Aldrich) in blocking solution were used for detection. The signal was visualized using ECL plus western blotting detection system (Amersham Biosciences, Uppsala, Sweden).
Primers used in RT-PCR
Name of primer
NKG5 sense A
5'-GTA TCT GTG GTA AAC CCA-3'
NKG5 sense B
5'-GCT CCC TGC CCA TAA AAC AG-3'
NKG5 sense C
5'-CAT CTC AGC GGC TGC CC-3'
exon 1 end sense
5'-GCT CCT TGC AGC CAT GCT C-3'
5'-GCC TCA TCG GTG GAT CTG CGT-3'
ST antisense (ex2)
5'-GCA GGA AGT CTG CCT TGA AC-3'
5'-GTG CTC GAG TTA CCT GAG GTC CTC ACA GAT CTG-3'
5'-TAT ACC ATG GGC CGG GAC CTG ACT GAC TAC-3'
5'-GTG CTC GAG GAA CCG CTC ATT GCC AAT GGT G-3'
We are grateful to Gery Barmettler for excellent technical help and to Lloyd Vaughan for language correction of the manuscript.
- Stenger S: Cytolytic T cells in the immune response to mycobacterium tuberculosis. Scand J Infect Dis. 2001, 33: 483-7. 10.1080/00365540110026584.View ArticlePubMedGoogle Scholar
- Kaufmann SH: Cell-mediated immunity: dealing a direct blow to pathogens. Curr Biol. 1999, 9: R97-9. 10.1016/S0960-9822(99)80059-1.View ArticlePubMedGoogle Scholar
- Pena SV, Hanson DA, Carr BA, Goralski TJ, Krensky AM: Processing, subcellular localization, and function of 519 (granulysin), a human late T cell activation molecule with homology to small, lytic, granule proteins. J Immunol. 1997, 158: 2680-8.PubMedGoogle Scholar
- Trapani JA, Smyth MJ: Killing by cytotoxic T cells and natural killer cells: multiple granule serine proteases as initiators of DNA fragmentation. Immunol Cell Biol. 1993, 71 (Pt 3): 201-8. 10.1038/icb.1993.22.View ArticlePubMedGoogle Scholar
- Pena SV, Krensky AM: Granulysin, a new human cytolytic granule-associated protein with possible involvement in cell-mediated cytotoxicity. Semin Immunol. 1997, 9: 117-25. 10.1006/smim.1997.0061.View ArticlePubMedGoogle Scholar
- Jongstra J, Schall TJ, Dyer BJ, Clayberger C, Jorgensen J, Davis MM, Krensky AM: The isolation and sequence of a novel gene from a human functional T cell line. J Exp Med. 1987, 165: 601-614. 10.1084/jem.165.3.601.View ArticlePubMedGoogle Scholar
- Houchins JP, Yabe T, McSherry C, Miyokawa N, Bach FH: Isolation and characterization of NK cell or NK/T cell-specific cDNA clones. J Mol Cell Immunol. 1990, 4: 295-304. discussion 305-6PubMedGoogle Scholar
- Manning WC, O'Farrell S, Goralski TJ, Krensky AM: Genomic structure and alternative splicing of 519, a gene expressed late after T cell activation. J Immunol. 1992, 148: 4036-42.PubMedGoogle Scholar
- Donlon TA, Krensky AM, Clayberger C: Localization of the human T lymphocyte activation gene 519 (D2S69E) to chromosome 2p12----q11. Cytogenet Cell Genet. 1990, 53: 230-1.View ArticlePubMedGoogle Scholar
- Hanson DA, Kaspar AA, Poulain FR, Krensky AM: Biosynthesis of granulysin, a novel cytolytic molecule. Mol Immunol. 1999, 36: 413-22. 10.1016/S0161-5890(99)00063-2.View ArticlePubMedGoogle Scholar
- Walch M, Eppler E, Dumrese C, Barman H, Groscurth P, Ziegler U: Uptake of granulysin via lipid rafts leads to lysis of intracellular Listeria innocua. J Immunol. 2005, 174: 4220-7.View ArticlePubMedGoogle Scholar
- Stenger S, Hanson DA, Teitelbaum R, Dewan P, Niazi KR, Froelich CJ, Ganz T, Thoma-Uszynski S, Melian A, Bogdan C, Porcelli SA, Bloom BR, Krensky AM, Modlin RL: An antimicrobial activity of cytolytic T cells mediated by granulysin. Science. 1998, 282: 121-5. 10.1126/science.282.5386.121.View ArticlePubMedGoogle Scholar
- Dieli F, Troye-Blomberg M, Ivanyi J, Fournie JJ, Krensky AM, Bonneville M, Peyrat MA, Caccamo N, Sireci G, Salerno A: Granulysin-dependent killing of intracellular and extracellular Mycobacterium tuberculosis by Vgamma9/Vdelta2 T lymphocytes. J Infect Dis. 2001, 184: 1082-5. 10.1086/323600.View ArticlePubMedGoogle Scholar
- Ochoa MT, Stenger S, Sieling PA, Thoma-Uszynski S, Sabet S, Cho S, Krensky AM, Rollinghoff M, Nunes Sarno E, Burdick AE, Rea TH, Modlin RL: T-cell release of granulysin contributes to host defense in leprosy. Nat Med. 2001, 7: 174-9. 10.1038/84620.View ArticlePubMedGoogle Scholar
- Stegelmann F, Bastian M, Swoboda K, Bhat R, Kiessler V, Krensky AM, Roellinghoff M, Modlin RL, Stenger S: Coordinate expression of CC chemokine ligand 5, granulysin, and perforin in CD8+ T cells provides a host defense mechanism against Mycobacterium tuberculosis. J Immunol. 2005, 175: 7474-83.View ArticlePubMedGoogle Scholar
- Walch M, Eppler E, Dumrese C, Barman H, Groscurth P, Ziegler U: Uptake of Granulysin via Lipid Rafts Leads to Lysis of Intracellular Listeria innocua. J Immunol. 2005, 174: 4220-4227.View ArticlePubMedGoogle Scholar
- Skoberne M, Schenk S, Hof H, Geginat G: Cross-presentation of Listeria monocytogenes-derived CD4 T cell epitopes. J Immunol. 2002, 169: 1410-8.View ArticlePubMedGoogle Scholar
- Harty JT, Tvinnereim AR, White DW: CD8(+) T cell effector mechanisms in resistance to infection [Review]. Annu Rev Immunol. 2000, 18: 275-308. 10.1146/annurev.immunol.18.1.275.View ArticlePubMedGoogle Scholar
- Vollenweider I, Moser R, Groscurth P: Development of four donor-specific phenotypes in human long-term lymphokine-activated killer cell cultures. Cancer Immunol Immunother. 1994, 39: 305-12.View ArticlePubMedGoogle Scholar
- Liu CC, Rafii S, Granelli-Piperno A, Trapani JA, Young JD: Perforin and serine esterase gene expression in stimulated human T cells. Kinetics, mitogen requirements, and effects of cyclosporin A. J Exp Med. 1989, 170: 2105-18. 10.1084/jem.170.6.2105.View ArticlePubMedGoogle Scholar
- Garcia-Sanz JA, MacDonald HR, Jenne DE, Tschopp J, Nabholz M: Cell specificity of granzyme gene expression. J Immunol. 1990, 145: 3111-8.PubMedGoogle Scholar
- Kelso A, Costelloe EO, Johnson BJ, Groves P, Buttigieg K, Fitzpatrick DR: The genes for perforin, granzymes A-C and IFN-gamma are differentially expressed in single CD8(+) T cells during primary activation. Int Immunol. 2002, 14: 605-13. 10.1093/intimm/dxf028.View ArticlePubMedGoogle Scholar
- Janas ML, Groves P, Kienzle N, Kelso A: IL-2 Regulates Perforin and Granzyme Gene Expression in CD8+ T Cells Independently of Its Effects on Survival and Proliferation. J Immunol. 2005, 175: 8003-8010.View ArticlePubMedGoogle Scholar
- Zhou J, Zhang J, Lichtenheld MG, Meadows GG: A role for NF-kappa B activation in perforin expression of NK cells upon IL-2 receptor signaling. J Immunol. 2002, 169: 1319-25.View ArticlePubMedGoogle Scholar
- Trapani JA, Klein JL, White PC, Dupont B: Molecular cloning of an inducible serine esterase gene from human cytotoxic lymphocytes. Proc Natl Acad Sci USA. 1988, 85: 6924-8. 10.1073/pnas.85.18.6924.PubMed CentralView ArticlePubMedGoogle Scholar
- Erickson HP, Bourdon MA: Tenascin: an extracellular matrix protein prominent in specialized embryonic tissues and tumors. Annu Rev Cell Biol. 1989, 5: 71-92. 10.1146/annurev.cb.05.110189.000443.View ArticlePubMedGoogle Scholar
- Speek M, Njunkova O, Pata I, Valdre E, Kogerman P: A potential role of alternative splicing in the regulation of the transcriptional activity of human GLI2 in gonadal tissues. BMC Mol Biol. 2006, 7: 13-10.1186/1471-2199-7-13.PubMed CentralView ArticlePubMedGoogle Scholar
- Willingham AT, Orth AP, Batalov S, Peters EC, Wen BG, Aza-Blanc P, Hogenesch JB, Schultz PG: A strategy for probing the function of noncoding RNAs finds a repressor of NFAT. Science. 2005, 309: 1570-3. 10.1126/science.1115901.View ArticlePubMedGoogle Scholar
- Erdmann VA, Barciszewska MZ, Hochberg A, de Groot N, Barciszewski J: Regulatory RNAs. Cell Mol Life Sci. 2001, 58: 960-77. 10.1007/PL00000913.View ArticlePubMedGoogle Scholar
- Mattick JS: Non-coding RNAs: the architects of eukaryotic complexity. EMBO Rep. 2001, 2: 986-91. 10.1093/embo-reports/kve230.PubMed CentralView ArticlePubMedGoogle Scholar
- Ma LL, Spurrell JC, Wang JF, Neely GG, Epelman S, Krensky AM, Mody CH: CD8 T cell-mediated killing of Cryptococcus neoformans requires granulysin and is dependent on CD4 T cells and IL-15. J Immunol. 2002, 169: 5787-95.View ArticlePubMedGoogle Scholar
- Obata-Onai A, Hashimoto S, Onai N, Kurachi M, Nagai S, Shizuno K, Nagahata T, Mathushima K: Comprehensive gene expression analysis of human NK cells and CD8(+) T lymphocytes. Int Immunol. 2002, 14: 1085-98. 10.1093/intimm/dxf086.View ArticlePubMedGoogle Scholar
- Ma LL, Wang CL, Neely GG, Epelman S, Krensky AM, Mody CH: NK cells use perforin rather than granulysin for anticryptococcal activity. J Immunol. 2004, 173: 3357-65.View ArticlePubMedGoogle Scholar
- Zheng CF, Ma LL, Jones GJ, Gill MJ, Krensky AM, Kubes P, Mody CH: Cytotoxic CD4+ T cells use granulysin to kill Cryptococcus neoformans, and activation of this pathway is defective in HIV patients. Blood. 2007, 109: 2049-57. 10.1182/blood-2006-03-009720.View ArticlePubMedGoogle Scholar
- Smyth MJ, Ortaldo JR, Shinkai Y, Yagita H, Nakata M, Okumura K, Young HA: Interleukin 2 induction of pore-forming protein gene expression in human peripheral blood CD8+ T cells. J Exp Med. 1990, 171: 1269-81. 10.1084/jem.171.4.1269.View ArticlePubMedGoogle Scholar
- Kojima Y, Kawasaki-Koyanagi A, Sueyoshi N, Kanai A, Yagita H, Okumura K: Localization of Fas ligand in cytoplasmic granules of CD8(+) cytotoxic T lymphocytes and natural killer cells: participation of Fas ligand in granule exocytosis model of cytotoxicity. Biochem Biophys Res Commun. 2002, 296: 328-10.1016/S0006-291X(02)00841-0.View ArticlePubMedGoogle Scholar
- Ohashi Y, Takeshita T, Nagata K, Mori S, Sugamura K: Differential expression of the IL-2 receptor subunits, p55 and p75 on various populations of primary peripheral blood mononuclear cells. J Immunol. 1989, 143: 3548-3555.PubMedGoogle Scholar
- Paschen A, Dittmar KE, Grenningloh R, Rohde M, Schadendorf D, Domann E, Chakraborty T, Weiss S: Human dendritic cells infected by Listeria monocytogenes: induction of maturation, requirements for phagolysosomal escape and antigen presentation capacity. Eur J Immunol. 2000, 30: 3447-56. 10.1002/1521-4141(2000012)30:12<3447::AID-IMMU3447>3.0.CO;2-M.View ArticlePubMedGoogle Scholar
- Kolb-Maurer A, Gentschev I, Fries HW, Fiedler F, Brocker EB, Kampgen E, Goebel W: Listeria monocytogenes-infected human dendritic cells: uptake and host cell response. Infect Immun. 2000, 68: 3680-8. 10.1128/IAI.68.6.3680-3688.2000.PubMed CentralView ArticlePubMedGoogle Scholar
- Lauvau G, Glaichenhaus N: Mini-review: Presentation of pathogen-derived antigens in vivo. Eur J Immunol. 2004, 34: 913-20. 10.1002/eji.200424944.View ArticlePubMedGoogle Scholar
- Song Z, Steller H: Death by design: mechanism and control of apoptosis. Trends Cell Biol. 1999, 9: M49-52. 10.1016/S0962-8924(99)01670-0.View ArticlePubMedGoogle Scholar
- Ortiz BD, Nelson PJ, Krensky AM: Switching gears during T-cell maturation: RANTES and late transcription. Immunol Today. 1997, 18: 468-71. 10.1016/S0167-5699(97)01128-6.View ArticlePubMedGoogle Scholar
- Filgueira L, Nestle FO, Rittig M, Joller HI, Groscurth P: Human dendritic cells phagocytose and process Borrelia burgdorferi. J Immunol. 1996, 157: 2998-3005.PubMedGoogle Scholar
- Image J. [http://rsb.info.nih.gov/ij]
This article is published under license to BioMed Central Ltd. This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.